Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Physical Growth”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03067298
What this trial is testing

Prediction of Preeclampsia and Other Pregnancy Complications Following Combined Iterative Screening

Who this might be right for
PreeclampsiaPreterm BirthFetal Growth Restriction+1 more
Emmanuel Bujold 805
Not applicableStudy completedNCT02542865
What this trial is testing

Investigate the Impact of Fortified Malt Based on Immunity Outcomes in School Children

Who this might be right for
Growth and Development
GlaxoSmithKline 924
Not applicableStudy completedNCT04218929
What this trial is testing

Evaluation of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants

Who this might be right for
InfantsNewborn
ByHeart 311
Post-approval studies (Phase 4)Study completedNCT05281341
What this trial is testing

Effect of GH Administration in Poor Responders Undergoing Intracytoplasmic Sperm Injection (ICSI)

Who this might be right for
Female Infertility
Alexandria University 160
Post-approval studies (Phase 4)Study completedNCT00287677
What this trial is testing

Induction and Expansion of T Cell Repertoire Using Growth Hormone and Vaccination in HIV-1 Infected Patients

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 33
Large-scale testing (Phase 3)Ended earlyNCT03656536
What this trial is testing

Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma

Who this might be right for
Unresectable CholangiocarcinomaMetastatic Cholangiocarcinoma
Incyte Corporation 167
Large-scale testing (Phase 3)Active Not RecruitingNCT05870319
What this trial is testing

A Phase III Study of SKB264 for EGFR Mutant NSCLC Patients

Who this might be right for
Non-small Cell Lung Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 376
Post-approval studies (Phase 4)WithdrawnNCT01891500
What this trial is testing

Early iNO for Oxidative Stress, Vascular Tone and Inflammation in Babies With Hypoxic Respiratory Failure

Who this might be right for
Persistent Fetal Circulation SyndromeHypertension, Pulmonary, of Newborn, PersistentPersistent Pulmonary Hypertension of Newborn
University of Florida
Post-approval studies (Phase 4)Not Yet RecruitingNCT07171086
What this trial is testing

AI-POCUS for Maternal and Neonatal Health in Ethiopia

Who this might be right for
PregnancyPregnancy ComplicationsPreterm Birth+3 more
Tsinghua University 1,059
Not applicableEnrolling By InvitationNCT05718570
What this trial is testing

Follow Patients With Adult Growth Hormone Deficiency (AGHD) Treated With Sogroya® for Long Term Safety Information

Who this might be right for
Adult Growth Hormone Deficiency
Novo Nordisk A/S 400
Large-scale testing (Phase 3)Study completedNCT00884000
What this trial is testing

Zomacton in Children With Growth Hormone Deficiency

Who this might be right for
Growth Hormone Deficiency
Ferring Pharmaceuticals 165
Not applicableStudy completedNCT04763512
What this trial is testing

Clinical Study of Partially Hydrolysed Protein Infant Formula on Trans-epidermal Water Loss (TEWL)

Who this might be right for
Atopic DermatitisSkin Condition
Société des Produits Nestlé (SPN) 200
Large-scale testing (Phase 3)Looking for participantsNCT07062965
What this trial is testing

Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Who this might be right for
Breast Cancer
Pfizer 400
Not applicableActive Not RecruitingNCT03651505
What this trial is testing

X-linked Hypophosphatemia Disease Monitoring Program

Who this might be right for
X-linked HypophosphatemiaHypophosphatemic Rickets
Ultragenyx Pharmaceutical Inc 782
Large-scale testing (Phase 3)Looking for participantsNCT07071337
What this trial is testing

SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy

Who this might be right for
Metastatic Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 430
Large-scale testing (Phase 3)Study completedNCT00637377
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Bayer 1,240
Not applicableStudy completedNCT01429467
What this trial is testing

Glucose Variability in Type 1 Diabetes and Its Effect on Factors That Influence New Vessel Formation

Who this might be right for
Type 1 Diabetes
University of Dundee 35
Large-scale testing (Phase 3)Ended earlyNCT06038539
What this trial is testing

Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer

Who this might be right for
HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
Biocon Biologics UK Ltd 55
Not applicableStudy completedNCT06506981
What this trial is testing

Impact of Electrolyte Intake (Sodium, Phosphorus) on the Growth of Premature Newborns

Who this might be right for
Postnatal Growth Disorder
Central Hospital, Nancy, France 684
Not applicableWithdrawnNCT00985036
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients

Who this might be right for
GliomaMeningioma
Marquette General Health System
Next Page